Medtech
Bringing cutting edge capabilities in design, digital and analytics to create innovative products, devices, equipment, software, and solutions that enhance patient value and outcomes.
Generics and Biosimilars
Helping companies capture opportunities across the value chain for generics, branded generics, established products and biosimilars, and forging connections among industry stakeholders.
Medical Affairs
Helping clients to transform their medical affairs function into the company’s third strategic pillar alongside R&D and commercial.
Operations
Using our operations expertise to drive performance, increase revenue, and enhance the bottom line.
Research & Development
Helping clients build the R&D capabilities needed to drive innovation, improve productivity and performance, and develop successful portfolio and asset strategies.
Commercial
Helping clients maximize commercial value by assisting with product launch, marketing, sales, and market access.
Biotech
Helping biotech companies across the entire value chain, from early-stage companies getting initial funding to established companies launching into international markets.
Digital Health and Health tech
Helping health tech businesses across the entire value chain, from start-ups in the initial stages of fundraising to established companies, expand into global markets.
POBOS
POBOS provides information on cost, productivity and quality, supply chain performance, and quality performance across more than 35 pharmaceutical and biotech companies. Companies can use the information to understand productivity drivers and their impact and quickly focus efforts on the highest value areas.
Scientific AI
We develop and deploy Artificial Intelligence methods to accelerate innovation and unlock value in Research and Development across industries. Our sophisticated Artificial Intelligence and Machine Learning capabilities have been developed to help across the entire R&D process.
How medtech companies can create value via inventory optimization
January 24, 2025 – With more efficient inventory management, medtechs can reduce inventory by up to 30 percent—freeing up cash and reducing…
Closing the women’s health gap: Biopharma’s untapped opportunity
January 22, 2025 – Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely,…
Putting people at the center of the R&D talent model in life sciences
January 9, 2025 – Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent. What R&D…
